These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 13274278)
41. [Dicumarol treatment in general practice]. SCHWAN W Ther Ggw; 1952 Oct; 91(10):370-1. PubMed ID: 13029065 [No Abstract] [Full Text] [Related]
42. Inhibition of the local Shwartzman reaction by dicumarol. SPANOUDIS S; EICHBAUM F; ROSENFELD G J Immunol; 1955 Sep; 75(3):167-70. PubMed ID: 13252255 [No Abstract] [Full Text] [Related]
43. [Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type]. TRONNBERG G Nord Med; 1955 Jun; 53(26):1028-9. PubMed ID: 13244879 [No Abstract] [Full Text] [Related]
44. Effect of phenylindanedione and dicumarol in experimental frostbite. LEPP E; CHUBATY W; JACQUES LB Can J Med Sci; 1953 Jun; 31(3):173-81. PubMed ID: 13059674 [No Abstract] [Full Text] [Related]
45. [The mechanism of action of dicumarol and related compounds]. MARTIUS C; NITZ-LITZOW D Biochim Biophys Acta; 1953; 12(1-2):134-40. PubMed ID: 13115422 [No Abstract] [Full Text] [Related]
46. Vitamin K control of the increased hypoprothrombinemic effect of dicumarol in congestive heart failure. COVERT DF Am J Med Sci; 1952 Oct; 224(4):439-45. PubMed ID: 12976389 [No Abstract] [Full Text] [Related]
47. Effect of dicumarol on localized Shwartzman reaction. ROTHFELD B; WILLIAMS CH; THALER WJ; RODAS JM Proc Soc Exp Biol Med; 1954 Oct; 87(1):5-7. PubMed ID: 13224659 [No Abstract] [Full Text] [Related]
48. [Excessive dosage of dicumarol and management of clinical manifestations and therapy of resulting hemorrhage]. KUSHELEVSKII BP Klin Med (Mosk); 1956 Mar; 34(3):74-5. PubMed ID: 13320746 [No Abstract] [Full Text] [Related]
50. Indications for dicumarol in acute myocardial infarction. RUSSEK HI; ZOHMAN BL; DOERNER AA; RUSSEK AS; WHITE LG Trans Am Coll Cardiol; 1951; 1():116-9. PubMed ID: 13005579 [No Abstract] [Full Text] [Related]
51. Observations on the coagulation disturbance in human plasma following the ingestion of dicumarol. BARKHAN P S Afr J Med Sci; 1954 Dec; 19(4):141-6. PubMed ID: 13255993 [No Abstract] [Full Text] [Related]
52. [Progress in management of dicumarol therapy; simplification of control; vitamin KI as antidote]. KOLLER F; LOELIGER A; FLUCKIGER P Helv Med Acta; 1952 Oct; 19(4-5):411-6. PubMed ID: 13021791 [No Abstract] [Full Text] [Related]
53. Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments. WESSLER S J Clin Invest; 1953 Jul; 32(7):650-4. PubMed ID: 13069611 [No Abstract] [Full Text] [Related]
55. Influence of long-term bishydroxycoumarin (dicumarol) therapy on liver function. MEITUS ML; WASSERMAN P AMA Arch Intern Med; 1953 Apr; 91(4):464-73. PubMed ID: 13039604 [No Abstract] [Full Text] [Related]
56. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin. TAGER M Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268 [No Abstract] [Full Text] [Related]
57. [Control of dicumarol therapy; relation between Quick's method and the P and P method of Owren and Aas]. BIANCO S; CROLLE G Minerva Med; 1956 May; 47(39):1486-9. PubMed ID: 13334118 [No Abstract] [Full Text] [Related]
58. Retroperitoneal hemorrhage simulating an acute abdominal lesion during dicumarol therapy. REITER MD W V Med J; 1956 Jul; 52(7):205-7. PubMed ID: 13353006 [No Abstract] [Full Text] [Related]
59. Dilution curves and accuracy in prothrombin estimations during hepatitis and dicumarol therapy. MULLERTZ S Scand J Clin Lab Invest; 1953; 5(2):179-87. PubMed ID: 13089547 [No Abstract] [Full Text] [Related]
60. The use of dicumarol in acute coronary thrombosis. SCHIFFLER RJ Marquette Med Rev; 1947 May; 12(3):166-71. PubMed ID: 20239117 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]